ADAMTS-13 assays in thrombotic thrombocytopenic purpura

被引:85
作者
Peyvandi, F. [1 ,2 ]
Palla, R. [1 ]
Lotta, L. A. [1 ]
Mackie, I. [2 ]
Scully, M. A. [2 ]
Machin, S. J. [2 ]
机构
[1] Univ Milan, Dept Med & Med Special,Luigi Villa Fdn, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Fdn IRCCS Ca Granda,Osped Maggiore Policlin, Milan, Italy
[2] UCL, Dept Haematol, Haemostasis Res Unit, London, England
关键词
ADAMTS-13; assays; clinical utility; standardization; VON-WILLEBRAND-FACTOR; FACTOR-CLEAVING PROTEASE; HEMOLYTIC-UREMIC SYNDROME; ANTI-ADAMTS13; ANTIBODIES; FRETS-VWF73; ASSAY; ENZYME-IMMUNOASSAY; PROGNOSTIC VALUE; PLASMA-EXCHANGE; IGG ANTIBODIES; MICROANGIOPATHIES;
D O I
10.1111/j.1538-7836.2010.03761.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ADAMTS-13, the thirteenth member of the ADAMTS (A Disintegrin And Metalloprotease with Thrombo-Spondin 1 repeats) family, is the plasma metalloprotease responsible for regulating the multimeric structure of VWF. In congenital or acquired deficiency it is actively involved in the pathophysiology of thrombotic thrombocytopenic purpura (TTP), a rare but life threatening disease characterized by microangiopathic haemolytic anaemia and consumptive thrombocytopenia leading to disseminated microvascular thrombosis and variable signs and symptoms of organ ischemia and damage. In the last few years, a number of in house and commercial laboratory assays for ADAMTS-13 and its autoantibodies have been developed. The features and clinical utility of ADAMTS-13 assays are summarized in this review.
引用
收藏
页码:631 / 640
页数:10
相关论文
共 67 条
[1]   The proximal carboxyl-terminal domains of ADAMTS13 determine substrate specificity and are all required for cleavage of von Willebrand factor [J].
Ai, JH ;
Smith, P ;
Wang, SW ;
Zhang, P ;
Zheng, XL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (33) :29428-29434
[2]   Evaluation and clinical application of a new method for measuring activity of von Willebrand factor-cleaving metalloprotease (ADAMTS13) [J].
Böhm, M ;
Vigh, T ;
Scharrer, I .
ANNALS OF HEMATOLOGY, 2002, 81 (08) :430-435
[3]   Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura [J].
Coppo, P ;
Wolf, M ;
Veyradier, A ;
Bussel, A ;
Malot, S ;
Millot, GA ;
Daubin, C ;
Bordessoule, D ;
Pène, F ;
Mira, JP ;
Heshmati, F ;
Maury, E ;
Guidet, B ;
Boulanger, E ;
Galicier, L ;
Parquet, N ;
Vernant, JP ;
Rondeau, E ;
Azoulay, E ;
Schlemmer, B .
BRITISH JOURNAL OF HAEMATOLOGY, 2006, 132 (01) :66-74
[4]  
Coppola R, 2003, HAEMATOLOGICA, V88, P39
[5]   Evaluation of ADAMTS-13 activity in plasma using recombinant von Willebrand Factor A2 domain polypeptide as substrate [J].
Cruz, MA ;
Whitelock, J ;
Dong, JF .
THROMBOSIS AND HAEMOSTASIS, 2003, 90 (06) :1204-1209
[6]   ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions [J].
Dong, JF ;
Moake, JL ;
Nolasco, L ;
Bernardo, A ;
Arceneaux, W ;
Shrimpton, CN ;
Schade, AJ ;
McIntire, LV ;
Fujikawa, K ;
López, JA .
BLOOD, 2002, 100 (12) :4033-4039
[7]   Bilirubin oxidase as a solution for the interference of hyperbilirubinemia with ADAMTS-13 activity measurement by FRETS-VWF73 assay [J].
Eckmann, C. M. ;
de Laaf, R. T. M. ;
van Keulen, J. M. ;
van Mourik, J. A. ;
de Laat, B. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (06) :1330-1331
[8]   IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura [J].
Ferrari, S. ;
Mudde, G. C. ;
Rieger, M. ;
Veyradier, A. ;
Hovinga, J. A. Kremer ;
Scheiflinger, F. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (10) :1703-1710
[9]   Prognostic value of anti-ADAMTS13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS13 activity [J].
Ferrari, Silvia ;
Scheiflinger, Friedrich ;
Rieger, Manfred ;
Mudde, Geert ;
Wolf, Martine ;
Coppo, Paul ;
Girma, Jean-Pierre ;
Azoulay, Elie ;
Brun-Buisson, Christian ;
Fakhouri, Fadi ;
Mira, Jean-Paul ;
Oksenhendler, Eric ;
Poullin, Pascale ;
Rondeau, Eric ;
Schleinitz, Nicolas ;
Schlemmer, Benoit ;
Teboul, Jean-Louis ;
Vanhille, Philippe ;
Vernant, Jean-Paul ;
Meyer, Dominique ;
Veyradier, Agnes .
BLOOD, 2007, 109 (07) :2815-2822
[10]   ADAMTS-13 plasma level determination uncovers antigen absence in acquired thrombotic thrombocytopenic purpura and ethnic differences [J].
Feys, HB ;
Liu, F ;
Dong, N ;
Pareyn, I ;
Vauterin, S ;
Vandeputte, N ;
Noppe, W ;
Ruan, C ;
Deckmyn, H ;
Vanhoorelbeke, K .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (05) :955-962